Epinogen

R&D company that develops next-generation anticancer drugs based on advanced Cryo-EM technology

More

Epinogen

R&D company that develops next-generation anticancer drugs based on advanced Cryo-EM technology

More

Epinogen

R&D company that develops next-generation anticancer drugs based on advanced Cryo-EM technology

More

Company Profile

Epinogen is a first-in-class anticancer drug discovery company based on advanced cryo-EM technology.

R&D Center

  • 01

    Main Technology

    Epinogen Co., Ltd. has world-class advanced ultra-low temperature electron microscope structure identification technology, new drug target giant protein production and research technology, and ultra-fast structure-based ligand optimization technology.

    More
  • 02

    Pipeline

    Epinogen Co., Ltd. has four leading pipelines and five follow-up pipelines, and aims to build and license out continuously.

    More
  • 03

    Research Content

    The excellence of targets by pipeline owned by Epinogen Co., Ltd. and major research contents.

    More

Notice

location

  • Headquarter

    Headquarter: 2F 203-B63, 15, Gyeryong-ro 105beon-gil, Yuseong-gu, Daejeon, Republic of Korea

  • Research institute

    Research institute: 604, KBIZ DMC Tower, 189, Seongam-ro, Mapo-gu, Seoul, Korea 03929